EXPRESSION OF FAS ANTIGEN AND BEL-2 IN HUMAN GLOMERULONEPHRITIS

被引:87
作者
TAKEMURA, T [1 ]
MURAKAMI, K [1 ]
MIYAZATO, H [1 ]
YAGI, K [1 ]
YOSHIOKA, K [1 ]
机构
[1] KINKI UNIV,SCH MED,DEPT PEDIAT,SAYAMA,OSAKA 589,JAPAN
关键词
D O I
10.1038/ki.1995.487
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To understand the regulatory mechanism of apoptosis in human glomerulonephritis, we examined the expression of Fas antigen (CD95) and Bcl-2 in five normal human kidney specimens and 80 tissues from patients with several types of glomerular diseases. These proteins were detected in glomeruli by immunofluorescence. The number of intraglomerular cells positive for Fas antigen was high in Henoch-Schonlein purpura nephritis and lupus nephritis, and that of Bcl-2-positive intraglomerular cells was high in lupus nephritis, focal glomerular sclerosis, and IgA nephritis. Dual-labeling and staining on serial sections indicated that mesangial cells and occasionally infiltrating leukocytes expressed Fas antigen and Bcl-2. In situ hybridization detected Bcl-2 mRNA in glomerular cells. Electron microscopy revealed apoptotic cells and apoptotic bodies in proliferated mesangial areas and within the glomerular capillaries. Fragmented DNA was detected in glomeruli by ill situ nick end labeling, the data of which paralleled the number of Fas antigen-positive intraglomerular cells. In mesangial proliferative types of glomerulonephritis, the population of Bcl-2-positive intraglomerular cells, but not that of Fas antigen-positive cells, was significantly correlated with the number of proliferating cell nuclear antigen-positive glomerular cells, the grade of mesangial cell increase, and the magnitude of proteinuria. This study showed that Fas antigen and Bcl-2 are up-regulated in the glomeruli of several types of human renal diseases. Bcl-2 overexpression might play a role in the prolonged proliferation of mesangial cells and glomerular hypercellularity in glomerulonephritis.
引用
收藏
页码:1886 / 1892
页数:7
相关论文
共 26 条
[1]  
BAGCHUS WM, 1986, LAB INVEST, V55, P680
[2]  
Cameron JS, 1988, DISEASES KIDNEY, P2127
[3]   APOPTOSIS AND EXPRESSION OF THE BCL-2 PROTOONCOGENE IN THE FETAL AND ADULT HUMAN KIDNEY - EVIDENCE FOR THE CONTRIBUTION OF BCL-2 EXPRESSION TO RENAL CARCINOGENESIS [J].
CHANDLER, D ;
ELNAGGAR, AK ;
BRISBAY, S ;
REDLINE, RW ;
MCDONNELL, TJ .
HUMAN PATHOLOGY, 1994, 25 (08) :789-796
[4]  
CHARLOTTE F, 1994, AM J PATHOL, V144, P460
[5]  
CHURG J, 1982, RENAL DISEASE CLASSI
[6]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[7]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[8]   CELL-DEATH IN THE DISEASED GLOMERULUS [J].
HARRISON, DJ .
HISTOPATHOLOGY, 1988, 12 (06) :679-683
[9]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[10]   BCL2 PROTEIN IS TOPOGRAPHICALLY RESTRICTED IN TISSUES CHARACTERIZED BY APOPTOTIC CELL-DEATH [J].
HOCKENBERY, DM ;
ZUTTER, M ;
HICKEY, W ;
NAHM, M ;
KORSMEYER, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :6961-6965